Dergiler / Haseki Tıp Bülteni / 2022 / Cilt: 60 - Sayı: 2

Laboratory Parameters Predict Complications in Primary Hyperparathyroidism: A Multicenter Cross-sectional Study

Sayfa
168–174
Yayın Tarihi
2022-10-17
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Although no risk factor could be found for nephrolithiasis, WIN was found as an independent risk factor for osteoporosis.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim: There is no study predicts the development of complications with laboratory parameters in patients with primary hyperparathyroidism (PHPT).
📊
Temel Bulgular & Veri:Methods: This multicenter retrospective cross-sectional study was conducted between January 2018 and January 2020.
💡
Sonuç & Katkı:Although no risk factor could be found for nephrolithiasis, WIN was found as an independent risk factor for osteoporosis.
🔬Tür:Araştırma Makalesi
📍Kapsam:2018 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Aim: There is no study predicts the development of complications with laboratory parameters in patients with primary hyperparathyroidism (PHPT). We aimed to determine the laboratory parameters that predict the development of osteoporosis or nephrolithiasis in patients with PHPT and identify high-risk patients. Methods: This multicenter retrospective cross-sectional study was conducted between January 2018 and January 2020. The study group consisted of 389 patients who were diagnosed with PHPT (68 patients without surgical indications and 321 patients with PHPT who underwent surgery), and 451 individuals without any additional disease as a control group. Patients’ data was obtained from the hospital automation system. All patients were divided into three groups (control, unoperated and operated), and laboratory parameters were compared. Results: The Wisconsin index (WIN), which is used to detect hyperfunctional glands in addition to parathyroid adenoma in PHPT, and the Parathyroid functional index (PFIndex), which is used to differentiate HPT secondary to vitamin D deficiency, can identify patients at high risk of nephrolithiasis or osteoporosis in patients with PHPT. In patients who have been operated on due to PHPT-related complications, the WIN value of 283.29 showed 95% sensitivity and 72% specificity in predicting osteoporosis, while the PFIndex of 36.43 had 86% sensitivity and 68% specificity for predicting nephrolithiasis. Conclusion: The WIN and PFIndex can be used to refer patients with PHPT for surgery before the onset of osteoporosis or nephrolithiasis. Although no risk factor could be found for nephrolithiasis, WIN was found as an independent risk factor for osteoporosis.

🔖

Bu Makaleye Atıf Yap

Cetin, Z., Catak, M., Baser, O. O., Koseoglu, D. (2022). Laboratory Parameters Predict Complications in Primary Hyperparathyroidism: A Multicenter Cross-sectional Study. Haseki Tıp Bülteni, Cilt: 60 - Sayı: 2, 168–174. https://ajindex.com/articles/534923

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Madeo B, Kara E, Cioni K, et al. Serum calcium to phosphorous (ca/p) ratio is a simple, inexpensive, and accurate tool in the diagnosis of primary hyperparathyroidism. JBMR Plus 2018;2:109-17
  2. Glendenning P, Bell DA, Clifton-Bligh RJ. Investigating hypophosphataemia. BMJ 2014;348:g3172
  3. Salcuni AS, Battista C, Pugliese F, et al. Normocalcemic primary hyperparathyroidism: an update. Minerva Endocrinologica 2020;46:262-71
  4. Walker MD, Silverberg SJ. Primary hyperparathyroidism. Nature Reviews Endocrinology 2018;14:115-25
  5. Zhu CY, Sturgeon C, Yeh MW. Diagnosis and Management of Primary Hyperparathyroidism. Jama 2020;323:1186-7
  6. Sencar ME, Sakiz D, Unsal IO, et al. Serum Vitamin D Level Does not Affect The Sensitivity of Parathyroid Adenoma Localization Tests. Scientific Reports 2019;9:1-6
  7. Guo Y, Wang Q, Lu C, et al. New parathyroid function index for the differentiation of primary and secondary hyperparathyroidism: a case-control study. BMC Endocrine Disorders 2020;20:5
  8. Muñoz de Nova JL, Sampedro-Nuñez M, Huguet-Moreno I, Marazuela Azpiroz M. A practical approach to normocalcemic primary hyperparathyroidism. Endocrine 2021;74:235-44
  9. Mazeh H, Chen H, Leverson G, Sippel RS. Creation of a “Wisconsin index” nomogram to predict the likelihood of additional hyperfunctioning parathyroid glands during parathyroidectomy. Annals of Surgery 2013;257:138-41
  10. Bilezikian JP, Brandi ML, Eastell R, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab 2014;99:3561-9
  11. Cormier C, Koumakis E. Bone and primary hyperparathyroidism. Jt Bone Spine 2022;89:105129
  12. De Pasquale L, Lori E, Bulfamante AM, Felisati G, Castellani L, Saibene AM. Evaluation of Wisconsin and CaPTHUS Indices Usefulness for Predicting Monoglandular and Multiglandular Disease in Patients with Primary Hyperparathyroidism through the Analysis of a Single-Center Experience. Int J Endocrinol 2021;2021
  13. Nilsson IL. Primary hyperparathyroidism: should surgery be performed on all patients? Current evidence and residual uncertainties. J Intern Med 2019;285:149-64
  14. Viccica G, Cetani F, Vignali E, Miccoli M, Marcocci C. Impact of vitamin D deficiency on the clinical and biochemical phenotype in women with sporadic primary hyperparathyroidism. Endocrine 2017;55:256-65
  15. Gollisch K, Siggelkow H. Asymptomatischer primärer Hyperparathyreoidismus. Der Internist 2021;